This internal document describes the outcomes and impact of the 2021 ICTR Clinical and Community Outcomes Research pilot award to Drs. Tova Walsh and Alvin Thomas. In collaboration with the African American Breastfeeding Network in Milwaukee, they completed a needs assessment among Black expectant fathers and mothers in Milwaukee, followed by a series of focus groups to gather community input to develop father-inclusive programming to support Black maternal and infant health.
Our very own Kattia Jimenez was honored as Emprendedora del Año by the Wisconsin Latino Chamber of Commerce during an elegant gala touted as the Latino Event of the Year.
Kattia, a project manager with the All of Us Research Program at the University of Wisconsin-Madison, is also the founder and owner of Mount Horeb Hemp LLC, a USDA certified organic hemp farm. She was recognized on August 13 at the Monona Terrace Convention Center for her entrepreneur vision and her efforts in advocating for the advancement of the hemp industry in Wisconsin.
Several ICTR and AoU-UW colleagues proudly attended gala, titled TRIBUTO, which pays homage to the inspiring culture, advancement, and economic contributions of Latinx entrepreneurs and their businesses across the state. The night included dinner, entertainment and remarks from Wisconsin Latino Chamber of Commerce CEO and President Jessica Cavazos.
Kattia, a Costa Rica native who formerly had a position with the CDC National Health and Nutrition Examination Survey, envisions limitless potential for the hemp industry in Wisconsin. She sees her business as a vehicle to promote economic empowerment in rural communities.
Join us in congratulating her!
With renewed grant support from the NIH Clinical and Translational Science Award and the Wisconsin Partnership Program (WPP), ICTR will fund 21 awards totaling $1.3 million to support clinical and translational research in Wisconsin. Christine Sorkness, PharmD, ICTR Senior Executive Director, notes,
ICTR is proud to celebrate renewal of our competitive grants from NIH and WPP by extending our uninterrupted record of funding awards that catalyze clinical and translational research and engage UW and Marshfield investigators, collaborators, and community partners. Importantly, the Pilot Awards Program continues to emphasize innovative research methods, team science, health equity, and impact.
As in previous years, we are partnering with UW departments and centers to sponsor specific awards, via our co-funding model. This approach allow both us and our partners to leverage scarce research funds to assist as many investigators as possible.
Co-funded awards are subject to an identical rigorous scientific review process, but post-review, institutional partners have the opportunity to select projects for co-funding that strategically align with their individual research priorities. The 2022 co-funding partnerships include the UW Carbone Cancer Center and the Department of Medicine’s Division of Geriatrics.
This year’s pilot portfolio includes Translational Basic & Clinical Pilot Awards (10), Novel Methods in Translational Science Pilot Grant Awards (4), Clinical & Community Outcomes Research Awards (4), Dissemination & Implementation Research Awards (2), and a Stakeholder & Patient Engaged Research Award. Awardees and their home departments span the entire UW campus, not just the schools and college that comprise the ICTR partnership (Engineering, Medicine & Public Health, Nursing, Pharmacy and Veterinary Medicine).
An 11-page list of Pilot Awards announced August 2022 (Uploaded 082922)File: 2022-Pilot-Award-Summaries.docx
E2I Scoring CriteriaFile: E2I-Scoring-Tool.pdf
Pre-proposals due July 15, 2022
Required Workshop (Virtual or Recording): June 15, 2022 – Register
The 2022 Evidence to Implementation (E2I) RFA has been released! The purpose of the E2I award is to facilitate and expedite the transfer or commercialization of evidence-based or evidence-informed practices, interventions, and innovations to appropriate end-users using the D&I Launchpad™. These include self-management or other health promotion workshops and interventions, and health services innovations that improve delivery of care in the health care or community setting. Previous awards are described here. Jane Mahoney, Director of the ICTR D&I Launchpad, notes,
The Launchpad team’s expertise will help with the future growth and sustainability of these healthcare innovations. These programs have incredible potential to make a significant impact on the health of Wisconsin and beyond
These awards will support creation of a Launchpad Package to support the dissemination and implementation of the evidence-based intervention or innovation. The elements of the Launchpad Package will be unique to each project, but may include a business plan – value proposition, marketing, sales, financials, intellectual property review, and any necessary tools and supporting materials.
The Evidence to Implementation Award (E2I) is funded by UW ICTR Pilots Awards Program, which is made possible by the UW SMPH Wisconsin Partnership Program through a Strategic Grant to the UW Institute for Clinical and Translational Research.
The deadline to submit a pre-proposal is July 15, 2022 (Uploaded 06/06/2022).File: 2022-RFA-EvidenceToImplementation.docx
RFA for the Evidence to Implementation Award (Uploaded 06/06/2022)
Uploaded 7/13/22File: Round-10-NM-Pilot-Awards.docx
Three early-career faculty have received the ICTR KL2 Career Development Award, starting July 1, 2021. These early-stage investigators join seven continuing scholars participating in the NIH-funded program that provides training, mentoring, and dedicated research time. Scholars are appointed for an initial two years, with the possibility of an additional two years. Please join us in welcoming the 2021 cohort:
- Gabriel Zayas-Caban, PhD, Assistant Professor of Industrial and Systems Engineering
The Average Effect of Emergency Department Admission Decisions for Older Adults with Chest Pain, Abdominal Pain, or Syncope
- Hilary Faust, MD, Assistant Professor of Medicine
Contribution of Mitochondrial DNA and Toll-Like Receptor 9 To ARDS Risk in Critically Ill Patients
- Matthew Harer, MD, Assistant Professor of Pediatrics
Investigating renal tissue oxygenation monitoring in preterm neonates for the early detection of AKI
Profiles of ICTR KL2 scholars can be found on the Career Development Awards page.
KL2 Scholars come from across the UW and Marshfield Clinic Research Institute and are diverse in degree, school, discipline, research topic, career development goals, and position on the translational spectrum.
The KL2 program employs a precision training approach, providing common training components and additional elective components. Corrine Voils, PhD, co-Director of the KL2 Program notes,
Our precision training approach carefully tailors the KL2 experience to each scholar’s needs. We ensure that scholars gain knowledge and skills to achieve personal, scientific, and career goals in an inclusive learning environment
The common component is delivered in the Mentored Scholars Seminar Series with cohort-specific sessions corresponding to year in the program. This training series targets 11 research competencies critical to scholars’ success as independent scientists, while also creating a cohort structure for peer support and collaboration. Manish Shah, MD, MPH, co-Director of the KL2 Program, adds,
Our training curriculum is open to other career development award recipients at UW, both those with independent awards and others in institutional programs across campus. This provides additional peer support for our scholars and allows ICTR to ‘give back’ to the larger UW ecosystem of research training.